CALM2 and breast carcinoma: In this context, it has been shown by ingenuity pathway analysis that the BDNF/TrkA (tropomyosin receptor kinase A) pathway regulates the network of MMPs and CaM in triple-negative human breast carcinoma cells modulating the interaction of tumor cells with endothelial cells [279].